Frank Asuncion

4.5k total citations
26 papers, 2.2k citations indexed

About

Frank Asuncion is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Oncology. According to data from OpenAlex, Frank Asuncion has authored 26 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Orthopedics and Sports Medicine and 15 papers in Oncology. Recurrent topics in Frank Asuncion's work include Bone Metabolism and Diseases (19 papers), Bone health and osteoporosis research (18 papers) and Bone health and treatments (15 papers). Frank Asuncion is often cited by papers focused on Bone Metabolism and Diseases (19 papers), Bone health and osteoporosis research (18 papers) and Bone health and treatments (15 papers). Frank Asuncion collaborates with scholars based in United States, Germany and United Kingdom. Frank Asuncion's co-authors include Michael S. Ominsky, Paul J. Kostenuik, Hua Zhu Ke, Mario Grisanti, Marina Stolina, W. Scott Simonet, Xiaodong Li, Denise Dwyer, Mary B. Kennedy and Randall S. Walikonis and has published in prestigious journals such as Journal of Neuroscience, Journal of Bone and Joint Surgery and Endocrinology.

In The Last Decade

Frank Asuncion

25 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Asuncion United States	23	1.6k	898	744	319	267	26	2.2k
P. Masarachia United States	20	1.2k 0.8×	1.3k 1.5×	893 1.2×	136 0.4×	180 0.7×	22	2.3k
Chris Pászty United States	19	1.6k 1.0×	771 0.9×	864 1.2×	382 1.2×	144 0.5×	25	2.5k
Mary Ann Mitnick United States	18	1.3k 0.8×	704 0.8×	395 0.5×	472 1.5×	157 0.6×	26	2.1k
Paul J. Yaworsky United States	16	1.5k 1.0×	278 0.3×	329 0.4×	362 1.1×	152 0.6×	26	1.9k
Frédéric Morvan Switzerland	14	1.2k 0.8×	306 0.3×	189 0.3×	288 0.9×	181 0.7×	16	1.7k
Katrien Janssens Belgium	19	1.0k 0.7×	431 0.5×	143 0.2×	514 1.6×	312 1.2×	43	1.8k
Naoshi Ogata Japan	27	1.5k 0.9×	561 0.6×	376 0.5×	429 1.3×	511 1.9×	53	2.6k
Julie Lacombe United States	21	800 0.5×	305 0.3×	230 0.3×	145 0.5×	139 0.5×	39	2.1k
Hosung Min United States	9	1.5k 1.0×	270 0.3×	141 0.2×	211 0.7×	126 0.5×	12	2.1k
Kenichi Nagano United States	23	812 0.5×	295 0.3×	185 0.2×	148 0.5×	125 0.5×	48	1.4k

Countries citing papers authored by Frank Asuncion

Since Specialization

Citations

This map shows the geographic impact of Frank Asuncion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Asuncion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Asuncion more than expected).

Fields of papers citing papers by Frank Asuncion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Asuncion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Asuncion. The network helps show where Frank Asuncion may publish in the future.

Co-authorship network of co-authors of Frank Asuncion

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Asuncion. A scholar is included among the top collaborators of Frank Asuncion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Asuncion. Frank Asuncion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiaodong, Frank Asuncion, Michael S. Ominsky, et al.. (2025). High-dose romosozumab promoted bone regeneration of critical-size ulnar defect filled with demineralized bone matrix in nonhuman primates. Journal of Orthopaedic Translation. 54. 1–7.

Florio, Mónica, Paul J. Kostenuik, Marina Stolina, et al.. (2023). Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone. Journal of Bone and Joint Surgery. 105(15). 1145–1155. 7 indexed citations

Li, Xiaodong, Frank Asuncion, Mario Grisanti, et al.. (2017). Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism. Bone. 105. 163–172. 25 indexed citations

Li, Xiaodong, Michael S. Ominsky, Qing‐Tian Niu, et al.. (2017). Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis. Endocrinology. 159(1). 260–271. 26 indexed citations

Li, Xiaodong, Qing‐Tian Niu, Kelly Warmington, et al.. (2014). Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody. Endocrinology. 155(12). 4785–4797. 59 indexed citations

Hamann, Christine, Martina Rauner, Ricardo Bernhardt, et al.. (2012). Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. Journal of Bone and Mineral Research. 28(3). 627–638. 103 indexed citations

Li, Xiaodong, Michael S. Ominsky, Kelly Warmington, et al.. (2011). Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats. Endocrinology. 152(9). 3312–3322. 71 indexed citations

Shahnazari, Mohammad, Denise Dwyer, Vivian Chu, et al.. (2011). Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. Bone. 50(3). 628–637. 30 indexed citations

Ominsky, Michael S., Hong‐Lin Tan, Mauricio Barrero, et al.. (2011). Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene. Bone. 49(6). 1178–1185. 61 indexed citations

10.

Heiland, Gisela Ruiz, Wolfgang Baum, Trayana Kireva, et al.. (2010). Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Annals of the Rheumatic Diseases. 69(12). 2152–2159. 171 indexed citations

11.

Li, Xiaodong, Kelly Warmington, Qing‐Tian Niu, et al.. (2010). Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats. Journal of Bone and Mineral Research. 25(12). 2647–2656. 191 indexed citations

12.

Ohishi, Masanobu, Riccardo Chiusaroli, Michael S. Ominsky, et al.. (2009). Osteoprotegerin Abrogated Cortical Porosity and Bone Marrow Fibrosis in a Mouse Model of Constitutive Activation of the PTH/PTHrP Receptor. American Journal Of Pathology. 174(6). 2160–2171. 24 indexed citations

13.

Li, Xiaodong, Michael S. Ominsky, Marina Stolina, et al.. (2009). Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin. Bone. 45(4). 669–676. 54 indexed citations

14.

Lloyd, Shane, Paul J. Kostenuik, Michael S. Ominsky, et al.. (2008). Soluble RANKL Induces High Bone Turnover and Decreases Bone Volume, Density, and Strength in Mice. Calcified Tissue International. 82(5). 361–372. 61 indexed citations

15.

Kostenuik, Paul J., Michael S. Ominsky, Sean Morony, et al.. (2007). Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease. Osteoporosis International. 19(5). 625–635. 25 indexed citations

16.

Li, Ji, Ildiko Sarosi, Russell C. Cattley, et al.. (2006). Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone. 39(4). 754–766. 348 indexed citations

17.

Stolina, Marina, Stephen Adamu, Denise Dwyer, et al.. (2005). RANKL is a Marker and Mediator of Local and Systemic Bone Loss in Two Rat Models of Inflammatory Arthritis. Journal of Bone and Mineral Research. 20(10). 1756–1765. 82 indexed citations

18.

Morony, Sean, Kelly Warmington, Stephen Adamu, et al.. (2005). The Inhibition of RANKL Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared with Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy. Endocrinology. 146(8). 3235–3243. 82 indexed citations

19.

Morony, Sean, Kelly Warmington, Stephen Adamu, et al.. (2005). The RANKL Inhibitor Osteoprotegerin (OPG) Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared to Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy. 11 indexed citations

20.

Walikonis, Randall S., Asako Oguni, Eugenia M. Khorosheva, et al.. (2001). Densin-180 Forms a Ternary Complex with the α-Subunit of Ca²⁺/Calmodulin-Dependent Protein Kinase II and α-Actinin. Journal of Neuroscience. 21(2). 423–433. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact